Peter E. Daddona

6.0k total citations · 1 hit paper
99 papers, 4.6k citations indexed

About

Peter E. Daddona is a scholar working on Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter E. Daddona has authored 99 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 32 papers in Physiology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter E. Daddona's work include Adenosine and Purinergic Signaling (32 papers), Biochemical and Molecular Research (28 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Peter E. Daddona is often cited by papers focused on Adenosine and Purinergic Signaling (32 papers), Biochemical and Molecular Research (28 papers) and Monoclonal and Polyclonal Antibodies Research (17 papers). Peter E. Daddona collaborates with scholars based in United States, Canada and United Kingdom. Peter E. Daddona's co-authors include William N. Kelley, J.I. Nagy, Michel Cormier, John Ghrayeb, James A. Matriano, Scott A. Siegel, David J. Shealy, Junming Le, J Vilček and Yuh‐Fun Maa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Peter E. Daddona

98 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

1993 568 citations David Knight, Han Trinh et al. Molecular Immunology profile →

Peers

Countries citing papers authored by Peter E. Daddona

Since Specialization

Citations

This map shows the geographic impact of Peter E. Daddona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Daddona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Daddona more than expected).

Fields of papers citing papers by Peter E. Daddona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Daddona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Daddona. The network helps show where Peter E. Daddona may publish in the future.

Co-authorship network of co-authors of Peter E. Daddona

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Daddona. A scholar is included among the top collaborators of Peter E. Daddona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Daddona. Peter E. Daddona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis 2010 ·Pharmaceutical Research ·Peter E. Daddona, James A. Matriano, Jaap W. Mandema, Yuh‐Fun Maa	179
2	Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women 2009 ·The Journal of Clinical Endocrinology & Metabolism ·Felicia Cosman, Nancy E. Lane, Michael A. Bolognese, José Zanchetta, Pedro Alberto García-Hernández, (unknown), James A. Matriano, (unknown), Peter E. Daddona	107
3	Macroflux® Microprojection Array Patch Technology: A New and Efficient Approach for Intracutaneous Immunization 2002 ·Pharmaceutical Research ·James A. Matriano, Michel Cormier, Juanita Johnson, (unknown), (unknown), (unknown), Peter E. Daddona	275
4	Molecular Weight-Dependent Paracellular Transport of Fluorescent Model Compounds Induced by Palmitoylcarnitine Chloride across the Human Intestinal Epithelial Cell Line Caco-2 1998 ·Journal of drug targeting ·Anthony C. Chao, (unknown), Peter E. Daddona, (unknown), Joseph A. Fix	14
5	Antiflammin 1 peptide delivered non‐invasively by iontophoresis reduces irritantinduced inflammation in vivo 1997 ·Experimental Dermatology ·(unknown), (unknown), (unknown), Iris Leung, Michel Cormier, Peter E. Daddona	8
6	Reverse iontophoresis: monitoring prostaglandin E₂ associated with cutaneous inflammation in vivo 1997 ·Experimental Dermatology ·(unknown), (unknown), Peter E. Daddona, (unknown), Michel Cormier	21
7	The Mouse/Human Chimeric Monoclonal Antibody cA2 Neutralizes TNF In Vitro and Protects Transgenic Mice from Cachexia and TNF Lethality In Vivo 1995 ·Cytokine ·Scott A. Siegel, David J. Shealy, Marian T. Nakada, Junming Le, Donna S. Woulfe, Lesley Probert, George Kollias, John Ghrayeb, J Vilček, Peter E. Daddona	175
8	Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis 1993 ·Arthritis & Rheumatism ·Larry W. Moreland, R. Pat Bucy, Arabella B. Tilden, (unknown), Albert F. LoBuglio, M.B. Khazaeli, Michael P. Everson, Peter E. Daddona, John Ghrayeb, (unknown), Martin E. Sanders, William J. Koopman	92
9	Human Anti-Endotoxin Antibody HA-1A Mediates Complement-Dependent Binding of Escherichia coli J5 Lipopolysaccharide to Complement Receptor Type 1 of Human Erythrocytes and Neutrophils 1993 ·The Journal of Infectious Diseases ·Jeffrey Krieger, (unknown), Scott A. Siegel, D T Fearon, (unknown), (unknown), Ronald P. Taylor, Peter E. Daddona	21
10	Construction and initial characterization of a mouse-human chimeric anti-TNF antibody breakdown → 1993 ·Molecular Immunology ·David Knight, Han Trinh, Junming Le, Scott A. Siegel, David J. Shealy, Margaret McDonough, Bernard J. Scallon, (unknown), J Vilček, Peter E. Daddona, John Ghrayeb	568
11	Bispecific antibodies and retargeted cellular cytotoxicity: novel approaches to cancer therapy 1992 ·International Journal of Clinical & Laboratory Research ·John R. Wunderlich, Delia Mezzanzanica, María Garrido, (unknown), Peter E. Daddona, Sarah M. Andrew, Vincent R. Zurawski, Silvana Canevari, Maria I. Colnaghi, David M. Segal	4
12	Conjugation and evaluation of 7E3 x P4B6, a chemically crosslinked bispecific F(ab')2 antibody which inhibits platelet aggregation and localizes tissue plasminogen activator to the platelet surface 1992 ·Bioconjugate Chemistry ·(unknown), (unknown), Mary Ann Mascelli, (unknown), (unknown), (unknown), Peter E. Daddona	8
13	Tissue distribution of technetium 99m indium 111 labelled and iodine 123 ov tl 3 fab in ovarian carcinoma bearing nude mice 1991 ·Nuclear Medicine and Biology ·Leon F.A.G. Massuger, Roland A. M. J. Claessens, Koon Y. Pak, O.C. Boerman, Peter E. Daddona, Emile B. Koenders, Peter Kenemans, Frans H.M. Corstens	4
14	Evaluation of the monoclonal antibody and the use of technetium-99m-labeled Fab′ for the detection of pan adenocarcinoma 1991 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·Koon Y. Pak, Mark Nedelman, William E. Fogler, (unknown), Elaine V. Wilson, (unknown), (unknown), S. O. Warnaar, Peter E. Daddona	14
15	Radiolocalization of human prostate tumor in a mouse subrenal capsule model by monoclonal antibody turp‐27 1990 ·The Prostate ·George L. Wright, (unknown), Mark R. Klinger, (unknown), Mary Lou Beckett, Peter E. Daddona	5
16	Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen 1989 ·Cancer Immunology Immunotherapy ·William E. Fogler, Lee K. Sun, Mark R. Klinger, John Ghrayeb, Peter E. Daddona	13
17	Distribution, morphology and habenular projections of adenosine deaminase-containing neurons in the septal area of rat 1988 ·Brain Research ·William A. Staines, Takenori Yamamoto, Karen M. Dewar, Peter E. Daddona, Jonathan D. Geiger, J.I. Nagy	22
18	The organization and hypothalamic projections of the tuberomammillary nucleus in the rat: An immunohistochemical study of adenosine deaminase-positive neurons and fibers 1987 ·Neuroscience ·William A. Staines, Peter E. Daddona, J.I. Nagy	83
19	Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase. 1983 ·PubMed ·Masaru Kubota, Naoyuki Kamatani, Peter E. Daddona, Dennis A. Carson	13
20	[23] Radioimmunoassay of human adenosine deaminase 1981 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Peter E. Daddona, Michael A. Frohman, William N. Kelley	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact